Chiho Hirata‐Fukae

Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model

Chiho Hirata‐Fukae, Hui-Fang Li, Hyang-Sook Hoe et al. · Brain Research · 2008 · 286 citations

Neurodegenerative Diseases, Alzheimer's Disease, Genetics +10

A Neuronal Microtubule-Interacting Agent, NAPVSIPQ, Reduces Tau Pathology and Enhances Cognitive Function in a Mouse Model of Alzheimer’s Disease

Yasuji Matsuoka, Yan Jouroukhin, Audrey Gray et al. · Journal of Pharmacology and Experimental Therapeutics · 2008 · 213 citations

Intranasal NAP administration reduces accumulation of amyloid peptide and tau hyperphosphorylation in a transgenic mouse model of Alzheimer's disease at early pathological stage

Yasuji Matsuoka, Audrey Gray, Chiho Hirata‐Fukae et al. · Journal of Molecular Neuroscience · 2007 · 164 citations

Amyloid Peptide, Alzheimer's Disease, Intranasal Nap Administration +9

BACE1 inhibition reduces endogenous Abeta and alters APP processing in wild‐type mice²

Kouhei Nishitomi, Gaku Sakaguchi, Yuko Horikoshi et al. · Journal of Neurochemistry · 2006 · 98 citations · Full text

A Humanin Derivative Reduces Amyloid Beta Accumulation and Ameliorates Memory Deficit in Triple Transgenic Mice

Takako Niikura, Elkhansa Sidahmed, Chiho Hirata‐Fukae et al. · PLoS ONE · 2011 · 72 citations · Full text